Antimicrobial susceptibility of bacterial isolates from community acquired infections in Sub‐Saharan Africa and Asian low and middle income countries
Open Access
- 24 June 2011
- journal article
- review article
- Published by Wiley in Tropical Medicine & International Health
- Vol. 16 (9), 1167-1179
- https://doi.org/10.1111/j.1365-3156.2011.02822.x
Abstract
Antimicrobial resistance has arisen across the globe in both nosocomial and community settings as a consequence of widespread antibiotic consumption. Poor availability of laboratory diagnosis means that resistance frequently goes unrecognised and may only be detected as clinical treatment failure. In this review, we provide an overview of the reported susceptibility of common community acquired bacterial pathogens in Sub-Saharan Africa and Asia to the antibiotics that are most widely used in these areas. We reviewed the literature for reports of the susceptibility of prevalent pathogens in the community in SSA and Asia to a range of commonly prescribed antibiotics. Inclusion criteria required that isolates were collected since 2004 and that they were obtained from either normally sterile sites or urine. The data were aggregated by region and by age group. Eighty-three studies were identified since 2004 which reported the antimicrobial susceptibilities of common bacterial pathogens. Different methods were used to assess in-vitro susceptibility in the different studies. The quality of testing (evidenced by resistance profiles) also varied considerably. For Streptococcus pneumoniae and Neisseria meningitidis most drugs maintained relatively high efficacy, apart from co-trimoxazole to which there were high levels of resistance in most of the pathogens surveyed. Compared with the enormous infectious disease burden and widespread use of antibiotics there are relatively few reliable data on antimicrobial susceptibility from tropical Asia and Africa upon which to draw firm conclusions, although it is evident that many commonly used antibiotics face considerable resistance in prevalent bacterial pathogens. This is likely to exacerbate morbidity and mortality. Investment in improved antimicrobial susceptibility testing and surveillance systems is likely to be a highly cost-effective strategy and should be complemented by centralized and readily accessible information resources.Keywords
This publication has 44 references indexed in Scilit:
- Community-acquired bloodstream infections in Africa: a systematic review and meta-analysisThe Lancet Infectious Diseases, 2010
- Community-associated meticillin-resistant Staphylococcus aureusThe Lancet, 2010
- Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimatesThe Lancet, 2009
- Antimicrobial Susceptibility and Mechanisms of Resistance in Shigella and Salmonella Isolates from Children under Five Years of Age with Diarrhea in Rural MozambiqueAntimicrobial Agents and Chemotherapy, 2009
- Antibiotic Susceptibility and Characteristics of Neisseria meningitidis Isolates from the African Meningitis Belt, 2000 to 2006: Phenotypic and Genotypic PerspectivesAntimicrobial Agents and Chemotherapy, 2009
- Causative agents and antimicrobial susceptibilities of urinary tract infections in the northwest of IranInternational Journal of Infectious Diseases, 2009
- Pathogens Associated With Sepsis in Newborns and Young Infants in Developing CountriesThe Pediatric Infectious Disease Journal, 2009
- A Multi-Center Randomised Controlled Trial of Gatifloxacin versus Azithromycin for the Treatment of Uncomplicated Typhoid Fever in Children and Adults in VietnamPLOS ONE, 2008
- Haemophilus influenzae type-b and non-b-type invasive diseases in urban children (years) of Bangladesh: Implications for therapy and vaccinationJournal of Infection, 2008
- Chloramphenicol versus ampicillin plus gentamicin for community acquired very severe pneumonia among children aged 2-59 months in low resource settings: multicentre randomised controlled trial (SPEAR study)BMJ, 2008